Discover
GLMD
Galmed Pharmaceuticals Ltd.
4.63
2 x 2.66
2 x 5.05
bid
ask
+
0.80
21.05%
2 @ 04:00 PM
0.57 -4.06 (87.61%)
| Ytd | 516.51% | |
| 1y | 158.66% |
3.82
day range
4.63
2.56
52 week range
23.80
| Open | 3.91 | Prev Close | 3.83 | Low | 3.82 | High | 4.63 | Mkt Cap | 5.02M |
| Vol | 301.15K | Avg Vol | 127.71K | EPS | 69.72 | P/E | 0.04 | Forward P/E | -2.94 |
| Beta | 0.80 | Short Ratio | 0.27 | Inst. Own | 0.48% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-01 | 50-d Avg | 3.25 | 200-d Avg | 4.07 | 1yr Est | 12.00 |
| Income Statement | |||
| Operating Expenses | 2.78M | ||
| Research and Development Expense | 1.78M | ||
| Selling, General and Administrative Expense | 993.00K | ||
| Operating Income | -2.77M | ||
| Interest Expense | -154.00K | ||
| Net Income | -2.72M | ||
| Net Income Common Stock | -2.72M | ||
| Net Income Common Stock (USD) | -2.72M | ||
| Consolidated Income | -2.72M | ||
| Earnings per Basic Share | -2.86 | ||
| Earnings per Basic Share (USD) | -2.86 | ||
| Earnings per Diluted Share | -2.86 | ||
| Earning Before Interest & Taxes (EBIT) | -2.88M | ||
| Earning Before Interest & Taxes (USD) | -2.88M | ||
| Weighted Average Shares | 952.17K | ||
| Weighted Average Shares Diluted | 952.17K | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.04M | ||
| Cash and Equivalents (USD) | 3.04M | ||
| Investments | 8.35M | ||
| Investments Current | 8.35M | ||
| Trade and Non-Trade Receivables | 323.00K | ||
| Current Assets | 11.71M | ||
| Property, Plant & Equipment Net | 164.00K | ||
| Total Assets | 18.28M | ||
| Debt Current | 83.00K | ||
| Total Debt | 129.00K | ||
| Current Liabilities | 2.81M | ||
| Debt Non-Current | 46.00K | ||
| Total Liabilities | 5.55M | ||
| Accumulated Retained Earnings (Deficit) | -215.41M | ||
| Accumulated Other Comprehensive Income | -331.00K | ||
| Shareholders Equity | 12.74M | ||
| Shareholders Equity (USD) | 12.74M | ||
| Assets Non-Current | 6.57M | ||
| Total Debt (USD) | 129.00K | ||
| Goodwill and Intangible Assets | 6.41M | ||
| Liabilities Non-Current | 2.73M | ||
| Trade and Non-Trade Payables | 2.73M | ||
| Tax Liabilities | 1.07M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 1.20M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.32M | ||
| Issuance (Purchase) of Equity Shares | 1.20M | ||
| Net Cash Flow from Investing | 2.24M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 5.43M | ||
| Net Cash Flow from Operations | -2.13M | ||
| Share Based Compensation | 156.00K | ||